EDTUTC-4 New YorkLog in Sign up

LTRN
Lantern Pharma Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:59 PM EDT

0.89USD-11.360%(-0.11)433,629

Pre-marketOct 2, 2026 9:29:30 AM EDT

1.03USD+3.000%(+0.03)

After-hoursOct 2, 2026 4:53:30 PM EDT

0.87USD-1.850%(-0.02)

LTRN News

Day breaks

08:08 AM EDTLantern Pharma announces up to $8M registered direct offering ·

Seeking Alpha

08:00 AM EDTLantern Pharma Inc. Announces up to $8 Million Registered Direct Offering ·

Business Wire

07:59 PM EDTLantern Pharma Inc. (LTRN) Discusses Open-Medicine AI Platform Roadmap, Business Model, and Value Proposition for Therapeutic Development Transcript ·

Seeking Alpha

07:45 AM EDTOpen-Medicine AI: Lantern Pharma to Present the Agentic AI Drug Development Market, User Needs, Development Roadmap, Platform Economics, and Benchmarks, Today at 12:30 PM ET ·

Business Wire

07:48 AM EDTLantern Pharma receives patent allowance for LP-284 cancer drug ·

Investing.com

07:45 AM EDTLantern Pharma Secures USPTO Notice of Allowance for LP‑284 Treatment Patent in Aggressive B‑Cell Lymphomas ·

Business Wire

08:20 AM EDTLantern Pharma to Present Open-Medicine AI — a Multi-Agentic Platform for End-to-End Therapeutic Development — Business Model, Roadmap, and Value Proposition on September 23 ·

Business Wire